AiMediq, a pioneering MedTech company headquartered in Luxembourg, stands as a leader in developing and commercialising IHHT® therapy. With more than a decade of research and development in hypoxia and breathing therapies, AiMediq has developed ReOxy®, a CE-marked medical device combining personalised oxygen modulation, medical hardware and advanced software algorithms to support rehabilitation and clinical care.
